Missed opportunities:a qualitative study of views and experiences of smoking cessation amongst adults in substance misuse treatment by Walsh, Hannah Elizabeth Alice et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1080/16066359.2018.1441403
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Walsh, H. E. A., Duaso, M., & McNeill, A. D. (2018). Missed opportunities: a qualitative study of views and
experiences of smoking cessation amongst adults in substance misuse treatment. ADDICTION RESEARCH
AND THEORY. https://doi.org/10.1080/16066359.2018.1441403
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
1 
 
This is an Accepted Manuscript of an article published by Taylor & Francis in Addiction 
Research and Theory online on 19th February 2018; available 
online: https://www.tandfonline.com/doi/full/10.1080/16066359.2018.1441403 
Missed opportunities: a qualitative study of views and experiences of 
smoking cessation amongst adults in substance misuse treatment 
Abstract  
Background: Smoking rates amongst people with a substance use disorder are 
disproportionately high. This study aimed to explore views and experiences of smoking and 
smoking cessation amongst people in substance misuse treatment in order to uncover novel 
perspectives which could assist in addressing this disparity. 
Methods: A qualitative research design was employed, using individual semi-structured 
interviews. The sample comprised 15 smokers and ex-smokers with a history of drug misuse 
who were recruited from four inner city substance misuse services. Interviews were audio 
recorded and analysed using the Framework method.  
Results: Several themes were uncovered, including the influence of the environment, peers 
and staff on motivation to quit and quit attempts; a complex link between smoking and 
substance use and the impact of substance misuse treatment experiences on attitudes 
towards smoking cessation. A number of missed opportunities were revealed, as well as 
unique factors affecting access to smoking cessation treatment for this population, 
demonstrating support for provision of smoking cessation treatment within both generic 
and specialist health services. 
Conclusions: People accessing substance misuse treatment seek to apply their learning from 
quitting illicit substances to smoking cessation. However, despite the availability of smoking 
cessation treatment including pharmacotherapy within substance misuse services and 
interest from service users, quit attempts were not encouraged or supported by substance 
misuse staff.  Opportunities to quit within such services are minimal, inconsistent and not 
aligned or sustained across services. 
Keywords 
Smoking cessation · Substance misuse treatment · Substance-use disorder · Tobacco use 
disorder • Qualitative research 
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Introduction 
The number of people smoking has fallen significantly in higher income countries in recent 
years (Jha et al. 2006), and in the UK is now at 15.8% (ONS 2017). However, amongst socially 
disadvantaged groups the number remains high, contributing to persistent health 
inequalities (Jha, et al. 2006, McNeill et al. 2012).  
Reported smoking prevalence amongst people with a substance use disorder (SUD) is 
between 85.9-98% (Guydish et al. 2016).  People with an SUD are at higher risk of 
premature mortality and morbidity in comparison to the general population and long-term 
tobacco use contributes substantially to this risk. Indeed smoking has been described as 
more potentially harmful to this population than their primary substance of misuse (Baca 
and Yahne 2009, Degenhardt and Hall 2012, Hurt et al. 1996).  
Despite policy in the UK and beyond recommending smoking cessation treatment is offered 
within substance misuse treatment settings (NICE 2013, Guydish et al. 2011), it appears to 
remain a low priority.  
An exploration of views and experiences providing insight into the high prevalence and low 
quit rates amongst people with an SUD is required.  Evidence suggests that many smokers 
with an SUD do wish to quit and have attempted to do so (Martinez et al. 2015). 
Quantitative studies have looked at factors influencing smoking cessation from both 
substance misuse treatment staff and service user perspectives, and found a focus on other 
substance abstinence rather than smoking cessation, concern at risk of relapse to substance 
use if tobacco use ceases, staff smoking and negative attitudes towards smoking cessation, 
and lack of access to or promotion of smoking cessation treatment within services (Baca and 
Yahne 2009, Cookson et al. 2014, McHugh et al. 2017, Richter et al. 2002, Thurgood et al. 
2015).  
Themes identified in qualitative studies include low risk perception of smoking, lack of 
smoking cessation treatment provision and promotion within substance misuse services, but 
also the potential for overlap of skills developed to address substance use (Cooperman et al. 
2015, Garner and Ratschen 2013, McCool and Richter 2003, Richter, et al. 2002, Wilson et 
al. 2016). A recent systematic review of qualitative studies of smoking cessation in 
substance misuse concluded that too little is done in substance misuse treatment settings to 
address the high prevalence of smoking, and that further research is required to develop the 
evidence base, which could then lead to specific smoking cessation treatments for these 
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smokers (Gentry et al. 2017). However, the review authors found the quality of reviewed 
studies moderate, and only one study was identified from the UK  which focussed on 
smokers with an SUD who were also homeless (Garner and Ratschen 2013).   
People with an SUD are a widely heterogeneous group, and substance-specific issues may 
play a factor in an individual’s views and experiences of smoking cessation. For example, the 
legal status of tobacco in contrast to illicit drugs may affect how individuals perceive 
continued tobacco use. Evidence pertaining to smoking cessation during substance misuse 
treatment also presents some variation according to substance. Some evidence suggests 
that opioid-dependent smokers may find nicotine-replacement therapy less effective than 
other smokers (Miller and Sigmon 2015), and evidence regarding the impact of smoking 
cessation on substance misuse outcomes is mixed. Two recent reviews found that 
participation in smoking cessation treatment did not impact on substance misuse treatment 
outcomes (Apollonio et al. 2016, McKelvey et al. 2017). In contrast, Joseph (Joseph et al. 
2004) found evidence of increased risk of relapse to alcohol post tobacco cessation. It may  
therefore be judicious to consider the views and experiences of people accessing substance 
misuse treatment for drug use separately to those with a history of solely alcohol use.  
The aim of this study is to identify factors influencing smoking and smoking cessation 
amongst people with a drug misuse disorder accessing substance misuse services in the UK.  
 
Design and methods 
The study used a qualitative design, collecting data by individual semi-structured interviews.  
Recruitment  
Purposive sampling was employed to identify people with a history of drug use who also 
smoked, or had recently quit. Motivation to quit was not a criteria for inclusion. Substance 
misuse services were used for recruitment to provide insight into experiences which could 
inform smoking cessation practice in such services. To provide a focus on the influence of 
drug use on smoking cessation experiences, people with solely an alcohol misuse disorder 
were excluded. 
Setting 
Two large organisations providing substance misuse treatment funded by local authority in a 
large urban area were contacted. Within the two organisations, services were chosen that 
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were able to facilitate recruitment and provided maximum sample variation.  The services 
comprised a detoxification (detox) unit, a residential rehabilitation service (rehab), a 
community service for people either homeless or in unstable accommodation, and a 
community group for women with additional complex social needs. All provided smoking 
cessation treatment and had implemented partial smoke-free policies.  
Prior to recruitment, the lead author (HW) met with a service user research consultation 
group to discuss the study design and to seek advice on recruitment and question style. 
Insight into the potential impact of discussing smoking cessation with this client group was 
provided.  
Study sample 
15 participants were recruited and interviewed between February and May 2016. A further 
five expressed an interest; two then declined and three did not meet inclusion criteria. 
Initial participants were all male, so an additional service was contacted and extra time was 
allocated to recruit female participants. The total of 15 participants was reached within 
available time resources, with an emphasis placed on gender balance rather than a larger 
sample.  Interviews lasted on average 45 minutes.  
Demographic information describing the sample is presented in Table 1. All participants 
were unemployed and had previous experience of substance misuse treatment; all smokers 
were daily, long-term smokers; some participants had spent time in prison. Participants 
have been assigned pseudonyms. 
Data collection 
An initial screening discussion took place with potential participants during which 
confidentiality was explained and informed consent for audio recording sought. HW (an 
experienced mental health nurse with research training) carried out the interviews which 
took place in a private area within the service. The interview schedule covered questions 
about smoking history, views of smoking in relation to drug use, views on smoking cessation 
and smoking cessation treatment, experiences of previous quit attempts and quit methods 
used; some participants additionally discussed their views and experiences of smoke free 
policies. The schedule was devised by the research team, and a pilot interview reviewed and 
the schedule adjusted before proceeding. The recorded interviews were transcribed by the 
interviewer then stored securely. 
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Reflexivity  
To promote reflexivity in the interview and analysis process, the interviewer discussed each 
interview with the research team, making use of field notes from the interviews, though 
these were not used in data analysis. Where any potential bias was identified, this was 
discussed and resolved with the research team, but must also be taken into account in 
interpreting the findings of this study.  
Analysis 
Transcripts were analysed using NVivo 10 software and identifying information removed. 
One transcript was coded inductively by two authors and a good degree of correlation 
found. All three researchers developed and refined the final concepts. Framework was 
selected as an analysis process because it allows for movement between stages and across 
cases and themes, considered useful for this study as participants were recruited from a 
number of services (Gale et al. 2013, Webster et al. 2014). Quotations which vividly 
portrayed aspects of each theme were selected. 
Results 
Influence of environment 
Participants described their smoking behaviour in the context of others’ behaviour, their 
environment and its’ social norms. For example, participants in detox reported that their 
smoking increased significantly on arrival. Reasons given included boredom and anxiety but 
smoking also facilitated social contact.  
Marlene initially intended to quit during treatment;  
I’d have to be by myself [to quit] … cos everybody in here smokes so it’s gonna be bloody 
hard! Everybody in here smokes, and I’d just feel a bit left out if I gave up (Marlene, 47, 
detox) 
Staff in treatment services were seen as role models, and their smoking behaviours, or use 
of e-cigarettes or NRT clearly influenced decisions made by participants. Participants were 
well aware of which staff smoked, and would use that to their advantage, e.g. asking a 
smoker to allow them a final cigarette even after the late curfew.  
The detox environment provided many cues to smoking and provision for smokers was 
described in positive terms. 
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… they built this big shelter with like proper nice cushioned covers, and you could go and sit 
down and relax … they’d gone out of their way to build this … the least we could do was to 
use it! (Geoff, 42, rehab). 
By contrast, Leroy described a previous experience in a totally smoke-free rehab. 
You’re in an environment where no-one smokes. So it’s not the norm. So you don’t have a 
chance to miss it, because no-one’s outside smoking … no-one comes in smelling of a 
cigarette (Leroy, 44, detox). 
Another participant described how the availability of smoking cessation treatment had 
triggered his quit attempt, 
It's at the hostel where I'm living at the moment, they've got a … smoking adviser that comes 
in on Wednesdays, and it was just that I noticed that she was there, and I decided, yeah, I'll 
have a go at that. (Eddie, 51, community) 
Similarly participants who had spent time in prison described this as a supportive 
environment for quitting. Access to pharmacotherapy and behavioural support was readily 
available, and offered a means to save money otherwise spent on tobacco. Though initially 
ambivalent, participants found they were able to quit and maintain abstinence in this 
structured environment.  
Complex interlink between smoking and substance use 
Participants described a very potent association between smoking and both drug and 
alcohol use. For some, the ritual of preparing to smoke or inject heroin always included 
preparing hand rolled cigarettes. These were smoked at a specific point in the process, 
sometimes to get rid of the taste of heroin, or to enhance its’ effect.  
By contrast when using alcohol, participants described an automated action of almost 
continual smoking, without being aware of how many cigarettes they were consuming.  
…the minute you give me a bevvy [drink], I’m gonna pick up a ciggy, cos they go hand in hand 
… the two of them fit each other like a hand in glove (Anthony, 42, detox) 
The attachment of smoking to drug and alcohol use appears reinforced by the increase in 
cigarette consumption whilst using drugs and alcohol.  
The physical harm caused by tobacco was acknowledged by most, and in some cases seen as 
more harmful than illicit substance use or alcohol use. However, the impact of substance 
misuse on many aspects of life made that a higher priority.   
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You know, you’re addicted to nicotine so I suppose it is really [a drug] but it’s just a drug that 
people don’t moan about (James, 57, rehab). 
Drug use had multiple negative impacts, whereas the perceived impact of smoking was 
restricted to health.  
Although participants may have expressed a desire to quit, some also felt ambivalent about 
the potential loss of smoking.  Smoking represented something legal that they felt 
permitted to hold on to, having given up other substances sometimes in response to 
external pressures.  
I think to myself: it’s the only luxury I’ve got left in life (Orla, 45, community) 
I’m coming off everything else, give me something!  (Leroy, 44, detox).  
 
Experiential learning from substance misuse treatment 
Though participants had varying views about the similarities of their smoking addiction to 
their substance addiction, they used their skills acquired in quitting substances when 
considering quitting smoking, with substitution being a key concept.  
‘Cos instead of taking heroin I take methadone, instead of smoking cigarettes I take these 
patches and mints you see, so I’m substituting, it occurred to me one day … that’s the way to 
go about it (Eddie, 51, community)  
All participants expected to use a form of pharmacotherapy in order to quit. Going ‘cold 
turkey’ was seen as unfeasible for them based on learning from previous drug or alcohol 
abstinence attempts. E-cigarettes were discussed by some, and identified as a means of 
substituting the behaviour of smoking with a less harmful alternative.  
If I’ve got something I could replace as a cigarette, you’re still gonna have nicotine in the 
thing aren’t you? So it’s like I’ll still be smoking but I won’t actually be smoking a cigarette 
(Marlene, 47, detox). 
Participants described a sense of self-efficacy gained from quitting drugs and alcohol, and 
told themselves if they could quit these, they could quit smoking. There was however 
limited recognition that smoking is highly addictive, so relapse to smoking became a source 
of self-criticism.  
8 
 
Missed opportunities 
On arrival in detox, participants were asked whether they were interested in smoking 
cessation, to which they commonly responded with surprise and apprehension. However, 
their confidence boosted by having achieved abstinence from drugs or alcohol and their 
motivation in smoking cessation emerged after a few days,  
... a lot of people have said they’re smoking a lot more when they’re coming into detox, so I 
guess when someone is examining their life, their future, and when their health is involved, I 
think, you know, that having smoking cessation, or just planting that seed in this 
environment, I think that might be quite useful in getting a smoker to kind of re-evaluate the 
harm that smoking is doing (Brian, 29, detox). 
However, staff were apparently unaware of any change in motivation since the first day, and 
participants often unaware that a smoking cessation adviser was available on site. No 
support or encouragement was offered at later stages in treatment.  
Participants expressed contrasting preferences for where they might access smoking 
cessation treatment. Some were satisfied with mainstream services such as a pharmacy, 
though not all were aware they may not need to pay for NRT if they were in receipt of free 
prescriptions. Others expressed a preference for receiving treatment via a health 
professional they already knew.  
Geoff described being encouraged by his general practitioner to access smoking cessation 
treatment outside of the consultation,   
… it’s just that little bit of I’ve got to go and do it with a person who I don’t know, and he 
[pharmacist] looks like he’s busy, making bags up with people’s medication, and I’m going 
‘excuse me bruv, 5 minutes, I wanna give up smoking, what do I do?’ And I’ve gotta have a 
consultation with him … if she [doctor] just turned round and went ‘right I’m giving you 
medication for your depression, I’m giving you medication for that, here’s some medication 
for your smoking’, I’d probably just go ‘right, ok, cool’ (Geoff, 42, rehab). 
Several participants similarly reported they would trust only what their own doctor 
prescribed, and were unwilling to discuss their history with someone they didn’t know.   
 
Women expressed specific concerns about disclosing tobacco and drug use. For example, 
when asked about accessing a mainstream smoking cessation service, Nadine stated she 
would be unlikely to, for fear of recrimination regarding her parenting role and capacity.  
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On the topic of a smoking cessation advisor attending the substance misuse service, Orla 
commented, 
Sometimes you're a bit wary of what can I mention to my doctor and what can't I, especially 
if you've got kids, but here [is different] (Orla, 45, community) 
The potential impact of gendered stigma is apparent. The perception that they wouldn’t be 
judged clearly enabled women to disclose and address substance use, which included 
tobacco, in a women-specific substance misuse service.  
Discussion 
In this study of views and experiences of smoking cessation amongst people in substance 
misuse treatment, a significant paradox has been highlighted. Participants describe 
motivation to quit which is enhanced by their experience of quitting other substances, they 
have immediate access to health professionals and cessation treatment and yet typically 
find their smoking rates increase. Despite expertise in quitting substances available from 
staff and peers alike, tobacco addiction appears to be neglected.  
Twyman et al (2014) describe common features which affect all vulnerable groups in 
addressing smoking cessation, such as lack of support from health professionals, but also 
stresses the importance of understanding the unique challenges that each group faces, 
pertaining to their own cultural and socio-economic contexts(Twyman et al. 2014); the 
current study drew out some of these unique experiences and considered the potential to 
address both addictions simultaneously (Twyman et al. 2014). 
The findings of the current study also reflect those of Gentry et al’s 2017 review; for 
example the complex interaction between substance and tobacco use which highlights the 
specific needs of this population, absence of support from healthcare professionals in 
making and sustaining quit attempts, and a wide variety of perceptions of smoking cessation 
treatment efficacy (Gentry, et al. 2017).  
This study supports and adds greater depth to these themes, and provides novel findings 
such as the influence of the treatment environment; preferences, including timing, for 
accessing smoking cessation treatment and the experiences of women in services.  
The influence of peers on both smoking and smoking cessation uptake identified in this 
study has been previously reported (Aschbrenner et al. 2015) as has the importance of 
peers within substance misuse treatment (Jason et al. 2006). The lack of advice and support 
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received by health professionals in substance misuse services has also been previously 
identified (Richter, et al. 2002). The implications of peer and staff influence are significant if 
smoking rates in this population are to be reduced.  
Strong associations with drug and alcohol use reported in this study suggest that smoking 
behaviour is intricately embedded in both substance use and daily life for this population. 
This association may explain some of the challenges in quitting that this population faces, 
and warrants further exploration in order to optimise smoking cessation interventions. 
Many participants referenced the legality and societal acceptance of tobacco in contrast to 
their primary substance of misuse, suggesting that this factor may have greater salience for 
people using illicit drugs.  
This study found that smokers with an SUD generally viewed tobacco as a less challenging 
addiction, which meant they felt discouraged when they ‘failed’ to quit. Providing education 
around the nature of tobacco addiction as well as careful assessment is required in case this 
decrease in self-efficacy increases the risk of relapse to other substance use, as well as 
encouraging repeated quit attempts.  
Though smokers in the general population may choose a variety of means to quit, this study 
suggests this population in particular support the use of pharmacotherapy, which may 
reflect experience and understanding of the rationale for substitution medication within 
substance misuse treatment. This contrasts with a previous qualitative study with 
marginalised groups which found that ‘cold turkey’ was viewed as the preferable quit 
method, although that study did not focus exclusively on people with an SUD (Pateman et 
al. 2016). Apollonio et al’s 2016 Cochrane review established that tobacco cessation therapy 
which included pharmacotherapy was most highly associated with tobacco abstinence 
amongst this population, though the quality of evidence on this topic was considered low 
(Apollonio, et al. 2016).  The review’s findings suggests that what works for the general 
population is what is likely to work for people with an SUD. The difference may lie in 
accessing such support.  It is vital to ensure that smokers with an SUD are fully aware of how 
to access smoking cessation treatment, and that these treatment services are accessible, 
regular and aligned with existing services.  
A number of missed opportunities throughout the recovery journey have been identified, 
the most conspicuous being within the detox period. Participants described how health 
professionals only ask about motivation to quit when service users arrive at detox, whereas 
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they appear more susceptible to a quit attempt later in the process when they have stopped 
their primary substance. The detox period therefore presents an opportunity for smokers to 
make use of their newly found self-efficacy in quitting substances. This would enable 
smokers to initiate pharmacotherapy and receive support from staff and peers alike around 
the clock, capitalising on the existing treatment environment as proposed by Bowman & 
Walsh (Bowman and Walsh 2003). We suggest that services ensure continued intervention 
on smoking cessation throughout the detox period.  
Similarly, health professionals who refer a service user on to a specific smoking cessation 
service may miss the opportunity to address the behaviour straightaway. UK guidelines for 
smoking cessation interventions in primary care indicate pharmacotherapy should be 
prescribed by the practitioner if an individual is unwilling to accept a referral on to an 
intensive smoking cessation support service. This study has shown that people with an SUD 
may be reluctant to access such a service for a variety of reasons; primary care practitioners 
as well as specialist treatment providers need to be aware of this and capitalise on any 
opportunity to provide treatment (NICE, 2006).  
For women who use substances, accessing mainstream services may present an additional 
challenge often due to concerns about their parenting capacity being questioned. Women 
with an SUD may therefore be under-represented in smoking cessation services, which 
could support previous research providing a rationale for women-specific services for both 
substance misuse and smoking cessation (Simpson and McNulty 2008, Torchalla et al. 2012).  
 
The COM-B model proposes that for any behaviour to occur, the person must have the 
capability, opportunity and motivation to carry it out (Michie et al. 2011). If this model is 
applied to the behaviour of making a quit attempt in the context of substance misuse 
treatment, then this study highlights the significance of opportunity. For participants who 
found themselves in a setting where smoking cessation treatment was readily available, the 
opportunity appeared to trigger the quit attempt. For those who had planned to quit on 
arrival in treatment, the opportunity was not provided as due to the very high prevalence of 
smoking they found it very challenging to make a quit attempt. Despite existing motivation 
and increased perception of capability since quitting other substances, without the 
opportunity they were not able to make their quit attempt as planned.  
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Substance misuse services need to be able to support those making planned quit attempts, 
but also to recognise that given the right opportunity, smokers may make unplanned quit 
attempts, as many do in the general population (West and Sohal 2006).  
The study succeeded in recruiting a demographically broad sample, reflective of substance 
misuse treatment demographic patterns. The sample size is small however, reflecting the 
additional time required for gender balanced recruitment in this particular treatment 
setting. The variety of services accessed provides a range of experiences and views, but only 
a small number of participants were recruited from each and the majority from detox 
services, reflecting experiences early on in the treatment pathway. However, similarities in 
experiences across services were identified and sufficient data generated to allow for 
analysis between cases. Further research could explore quitting rates and quitting 
experiences within each setting and at each stage of treatment pathway; this study provides 
a range of experiences reflecting the breadth and heterogeneity of substance misuse 
services, which may be transferred to other substance misuse populations.   
The professional nursing background of the interviewer could have introduced bias during 
the interview and analysis process with particular attention being paid to data pertaining to 
practice. The multi-disciplinary research team fostered a reflexive dialogue, which sought to 
address this potential bias.  
The potential for response bias is also acknowledged, though care was taken to reiterate to 
participants that the interviewer was entirely separate to the clinical service. A wish to 
produce socially desirable answers to a healthcare professional in a substance misuse 
treatment context is also likely, and may have influenced participants’ stated intentions and 
self-efficacy regarding their substance use but also their smoking behaviours.  
The study recruited mostly smokers motivated to quit smoking, therefore represents only a 
proportion of views from smokers with an SUD. Further research is required to elicit 
perspectives of those unmotivated to quit which could provide insight into what other 
potential interventions could reduce tobacco-related harm in this population.  
Conclusions  
Smokers with an SUD who took part in this study were, with a single exception, motivated to 
quit, they had the opportunity to transfer skills acquired from quitting substances, and 
regularly accessed health services. Efforts are needed to ensure those health services 
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promote and support smoking cessation that the treatment environment supports 
cessation, and that provision of smoking cessation treatment is fully accessible.  
Further research is required to determine effective smoking cessation interventions for this 
population within a substance misuse treatment setting. This study suggests that the 
influence of the environment, peers and staff needs to be taken into account in such 
interventions, as well as optimising the potential for transferring skills acquired in quitting 
substances.  Ensuring access to both pharmacotherapy and behavioural support is crucial in 
assisting this marginalised, high-risk population to reduce smoking-related harm.    
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